Dromex Group

Dromex Group serves as CEO at Dromex S.R.L.. Dromex S.R.L. operates in the pharmaceuticals sector with approximately 130.0 employees.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,465 c suite-level executives.

Outlook Microsoft Office 365 Cloudflare DNS CloudFlare Hosting WordPress.org Bootstrap Framework Google Maps (Non Paid Users) Mobile Friendly YouTube Google Font API Google Maps Apache Centro

comercializacion de productos farmaceuticos pharmaceutical manufacturing pharmaceutical ingredients active pharmaceutical ingredients apis excipients soft capsules quality control logistics support product development biotechnology pharmaceutical products market representation industrial scaling analytical support regulatory compliance new molecule supply latin america pharmaceutical business development clinical trials support innovation in pharma technical solutions pharmaceutical consulting supply chain management veterinary products stability studies regulatory assistance research & development drug formulation product registration market analysis laboratory services biological products customized pharmaceutical solutions global supply chain strategic partnerships manufacturing capabilities pharmaceutical market research quality assurance pharmaceutical distribution technical training project management raw materials supply compliance testing pharmaceutical contract manufacturing pharmaceutical technology transfer equipment validation project commercialization market-entry strategies patient safety industry standards healthcare compliance pharmaceuticals medical b2b logistics & supply chain productivity

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Dromex Group in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Dromex S.R.L..

Dromex Group's Position in the MessageCEO Database

• •Dromex Group is 1 of 1 verified executive contact we track at Dromex S.R.L..
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •25 verified contacts work at pharmaceuticals companies in the 130.0 employee range (same size as Dromex S.R.L.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Dromex Group directly?

Dromex Group's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Dromex S.R.L.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Dromex Group work for?

Dromex Group is CEO at Dromex S.R.L., a company in the pharmaceuticals sector with 130.0 employees.

Can I pitch or sell to Dromex Group?

As CEO at Dromex S.R.L., Dromex Group is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Dromex Group directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Dromex Group in?

Dromex Group works in the pharmaceuticals industry as CEO at Dromex S.R.L.. MessageCEO provides verified contact information for executives across all major industries.

Is Dromex Group's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Dromex Group's profile is kept up-to-date with the latest available information.

Last updated: October 30, 2026